Our Approach
MeTagic – Antibody Screening Platform
By fine-tuning the functionality of Fc fragment, the antibodies exhibited more potent antitumor efficacy in in vitro or in vivo models comparing to the parental antibodies. The development of the next generation antibody therapeutics can hence be accelerated.
3rdGO Innovative Engineering Platform
Advancing clinical improvement by using tri-specific drug conjugates and addressing poly-specific ADC issues on payload toxicity and clinical efficacy